Drugs like Wegovy, Ozempic would be covered by Medicare, Medicaid under Biden proposal
Millions of Americans would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic covered by Medicare and Medicaid under a rule the Biden administration has proposed.
Should Medicare, Medicaid Cover Anti-Obesity Drugs? Doctors Speak Out
Joe Biden wants diabetes drugs that aid weight loss and treat obesity, such as Wegovy, to fall under Medicare and Medicaid.
Biden proposes expanded Medicare, Medicaid coverage of obesity drugs
U.S. President Joe Biden on Tuesday proposed expanding coverage of anti-obesity drugs, like Novo Nordisk's Wegovy, for more than 7 million people with Medicare and Medicaid health coverage, which could cut out-of-pocket expenses for some by as much as 95%.
Biden proposes Medicare, Medicaid cover pricey weight-loss drugs for obese Americans
Millions of Americans could soon have access to weight-loss medications that some have called "miracle drugs."
Medicare May Soon Cover Ozempic, Wegovy Under New Biden Proposal
If the proposal is finalized, it could set the stage for a showdown between the pharmaceutical industry and the Trump administration.
Biden administration adds weight-loss drugs to Medicare
While recent advances in medicine have created prescription anti-obesity GLP-1 medications — like Ozempic, Wegovy, and Mounjaro — accessibility to these drugs is limited. The average prescription costs $1,
Biden's plan to cover anti-obesity drugs could cost $140 billion
President Joe Biden's plan to authorize Medicare and Medicaid cover anti-obesity medications starting in 2026 would $140 billion over the next decade.
Weight loss drugs like Wegovy, Ozempic would be covered by Medicare, Medicaid under Biden proposal
Millions of Americans with obesity would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic covered by Medicare and Medicaid under a new rule the Biden administration proposed Tuesday morning.
Cheap Ozempic? How millions of Americans with obesity may get access to costly weight-loss drugs
Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $35 billion proposal from the Biden administration is blessed by President-elect Donald Trump.
The future of Biden's plan for Medicaid to cover obesity drugs
Drugs used for weight loss like Wegovy and Zepbound could be covered by Medicare or Medicaid under a new proposal from the Biden administration.
My ‘warrior’ mom, 79, is in rehab after a life-changing fall. How do I win a Medicare appeal to keep her there?
I am gathering information for my first ever Medicare appeal for my mother, 79. She suffered a horrific fall in her home that ...
CNET1d
Make Medicare Changes During Open Enrollment: Everything You Need to Know
Medicare and Medicare Advantage plans are open for new signups and changes during this year's open enrollment period.
Big Pharma Pushes Trump Team to Ease Medicare Drug Price Negotiation Rules
Seven lobbyists and executives who work with top pharmaceutical and biotech companies told Reuters they are pushing to delay ...
Changes to Medicare in 2025
Changes to Medicare in 2025 include a cap on out-of-pocket prescription drug costs, changes to mental health care services, ...
3 Things Too Many Retirees Don't Know About Medicare
But unfortunately, because Medicare is a complex program consisting of different parts, a lot of retirees end up unclear ...
The American Journal of Managed Care11h
Medicare Competitive Bidding Program Cuts Spending Without Impacting COPD Outcomes
While the Medicare Competitive Bidding Program reduced spending, it did not significantly impact supplemental oxygen use or ...
TheStreet.com on MSN1d
Medicare Annual Election Period 2025: Key Tips and Expert Advice
The Medicare Annual Election Period (AEP) is a critical time for beneficiaries to review and update their coverage. In a ...
Medicare Advantage vs. Traditional Medicare
Medicare Advantage plans appeal to budget-conscious retirees with their low upfront premiums. However, they often entail ...